Tau pathology in AD is characterized by three interrelated processes: loss of microtubule-stabilizing function, gain of toxic function through soluble oligomers, and stereotyped, prion-like propagation across connected brain regions. The gene discussed is MAPT; the disease is Alzheimer disease.